BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28240361)

  • 1. Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.
    Odisio BC; Yamashita S; Huang SY; Harmoush S; Kopetz SE; Ahrar K; Shin Chun Y; Conrad C; Aloia TA; Gupta S; Hicks ME; Vauthey JN
    Br J Surg; 2017 May; 104(6):760-768. PubMed ID: 28240361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
    Calandri M; Yamashita S; Gazzera C; Fonio P; Veltri A; Bustreo S; Sheth RA; Yevich SM; Vauthey JN; Odisio BC
    Eur Radiol; 2018 Jul; 28(7):2727-2734. PubMed ID: 29417253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.
    Odisio BC; Yamashita S; Huang SY; Kopetz SE; Ahrar K; Mizuno T; Conrad C; Aloia TA; Chun YS; Gupta S; Vauthey JN
    J Vasc Interv Radiol; 2018 Mar; 29(3):395-403.e1. PubMed ID: 29395898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.
    Brudvik KW; Mise Y; Chung MH; Chun YS; Kopetz SE; Passot G; Conrad C; Maru DM; Aloia TA; Vauthey JN
    Ann Surg Oncol; 2016 Aug; 23(8):2635-43. PubMed ID: 27016292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases.
    Yamashita S; Odisio BC; Huang SY; Kopetz SE; Ahrar K; Chun YS; Conrad C; Aloia TA; Gupta S; Harmoush S; Hicks ME; Vauthey JN
    Eur J Surg Oncol; 2017 Jun; 43(6):1040-1049. PubMed ID: 28187878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.
    Shady W; Petre EN; Do KG; Gonen M; Yarmohammadi H; Brown KT; Kemeny NE; D'Angelica M; Kingham PT; Solomon SB; Sofocleous CT
    J Vasc Interv Radiol; 2018 Feb; 29(2):268-275.e1. PubMed ID: 29203394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab.
    Stremitzer S; Stift J; Gruenberger B; Tamandl D; Aschacher T; Wolf B; Wrba F; Gruenberger T
    Br J Surg; 2012 Nov; 99(11):1575-82. PubMed ID: 23027075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases.
    Denbo JW; Yamashita S; Passot G; Egger M; Chun YS; Kopetz SE; Maru D; Brudvik KW; Wei SH; Conrad C; Vauthey JN; Aloia TA
    J Gastrointest Surg; 2017 Jan; 21(1):68-77. PubMed ID: 27334313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
    Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
    Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
    Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
    World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.
    Kawaguchi Y; Lillemoe HA; Panettieri E; Chun YS; Tzeng CD; Aloia TA; Kopetz S; Vauthey JN
    J Am Coll Surg; 2019 Sep; 229(3):286-294.e1. PubMed ID: 31054911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailoring ablation strategies for colorectal liver metastases based upon rat sarcoma viral oncogene mutation status.
    Calandri M; Odisio BC
    Chin Clin Oncol; 2019 Oct; 8(5):51. PubMed ID: 31500432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes following microwave ablation for liver malignancies.
    Leung U; Kuk D; D'Angelica MI; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; Fong Y
    Br J Surg; 2015 Jan; 102(1):85-91. PubMed ID: 25296639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Bachet JB; Moreno-Lopez N; Vigano L; Marchese U; Gelli M; Raoux L; Truant S; Laurent C; Herrero A; Le Roy B; Deguelte Lardiere S; Passot G; Hautefeuille V; De La Fouchardiere C; Artru P; Ameto T; Mabrut JY; Schwarz L; Rousseau B; Lepère C; Coriat R; Brouquet A; Sa Cunha A; Benoist S
    Br J Surg; 2019 Aug; 106(9):1237-1247. PubMed ID: 31183866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type.
    Finkelstein SD; Sayegh R; Christensen S; Swalsky PA
    Cancer; 1993 Jun; 71(12):3827-38. PubMed ID: 8508351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.
    Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT
    Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat liver resection for colorectal metastases.
    Kulik U; Bektas H; Klempnauer J; Lehner F
    Br J Surg; 2013 Jun; 100(7):926-32. PubMed ID: 23640669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablative Margins of Colorectal Liver Metastases Using Deformable CT Image Registration and Autosegmentation.
    Lin YM; Paolucci I; O'Connor CS; Anderson BM; Rigaud B; Fellman BM; Jones KA; Brock KK; Odisio BC
    Radiology; 2023 Apr; 307(2):e221373. PubMed ID: 36719291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.